Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Athira Pharma Inc. logo

Athira Pharma Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

2.74
 
USD
  
0.18
  
(7.03%)
Optionable: Yes  Market Cap: 99 M  90-day average vol: 444,118

Previous close: 2.56  Open: 2.59  Bid: 2.63  Ask: 2.78
52 week range    
1.33   
   4.30
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 29th March 2024
41
MarketXLS Rank
60
Value
38
Technical
26
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

ATHA Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22
Basic EPS from continuing operations-1.49-2.53
Basic EPS total-1.49-2.53
Basic weighted shares outstanding12 M37 M38 M
Depreciation-2000.0479000.0845000.0
DepreciationAndAmortization-2000.0479000.0845000.0
Diluted EPS total-1.67-1.49-2.53
Diluted normalized net income/share-1.67-2.53
Diluted weighted shares outstanding12 M37 M38 M
GeneralAndAdministrativeExpense7 M21 M33 M
Income before tax-21 M-64 M-101 M
Interest income124000.0337000.0
InterestExpenseNonOperating-367000.03000.0
MiscOtherSpecialCharges-1 M334000.03 M
Net income from total operations-20 M-55 M-96 M
NetIncomeCommonStockholders-20 M-55 M-96 M
NetIncomeContinuousOperations-20 M-55 M-96 M
NetIncomeFromOtherGainsLosses1 M9 M5 M
NetNonOperatingInterestIncomeExpense491000.0334000.0
NonRecurringOperationExpense10 M
Operating income-20 M-64 M-104 M
Operating income before depreciation (EBITDA)-21 M-63 M-100 M
OperatingExpense20 M64 M94 M
Other income net1 M-334000.0-3 M
OtherGandA7 M21 M33 M
OtherOperatingExpenses323000.0368000.0
Research & development expense13 M43 M61 M
ResearchExpense13 M43 M61 M
SalariesAndWages-633000.0
Selling Gen & administrative expense7 M21 M33 M
Special income/charges-10 M
Total Income available for interest expense (EBIT)-22 M-64 M-101 M
Total common shares outstanding37 M38 M38 M
Total net income-20 M-55 M-96 M
Total ordinary shares38 M38 M38 M
TotalExpenses20 M64 M94 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University